Int. J. Environ. Res. Public Health 2012, 9 Acknowledgments 492 This work was supported by research grants from National Institutes of Health (R01-ES 11340). Conflict of Interest References There are no conflicts of interest. 1. U.S. EPA. Arsenic Compounds. 2011. Available online: http://www.epa.gov/ttnatw01/hlthef/ arsenic.html (accessed on 30 November 2011). 2. Kapaj, S.; Peterson, H.; Liber, K.; Bhattacharya, P. Human health effects from chronic arsenic poisoning—A review. J. Environ. Sci. Health Part A 2006, 41, 2399-2428. 3. Tapio, S.; Grosche, B. Arsenic in the aetiology of cancer. Mutat. Res. 2006, 612, 215-246. 4. EPHA. World Facing Increasing Threat of Arsenic Poisoning. 2012. Available online: http://www.epha.org/a/2750 (accessed on 23 January 2012). 5. Dutkiewicz, T. Experimental studies on arsenic absorption routes in rats. Environ. Health Perspect. 1977, 19, 173-176. 6. Jones, F.T. Invited review, a broad review of arsenic. Poultry Sci. 2007, 86, 2-14. 7. Guha Mazumder, D.N. Arsenic and non-malignant lung diseases. J Environ. Sci. Health Part A 2007, 42, 1859-1867. 8. Rossman, T.G. Mechanism of arsenic carcinogenesis: An integrated approach. Mutat Res. 2003, 533, 37-65. 9. Bertolero, F.; Pozzi, G.; Sabbioni, E.; Saffiott, U. Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis 1987, 8, 803-808. 10. Wang, T.C.; Jan, K.Y.; Wang, A.S.; Gurr, J.R. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat. Res. 2007, 615, 75-86. 11. Kitchin, K.T.; Wallace, K. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J. Inorg. Biochem. 2008, 102, 532-539. 12. Hughes, M.F. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 2002, 133, 1-16. 13. Jordan, M.A.; Wilson, L. Microtutules as a target for anticancer drugs. Nat. Rev. Cancer 2004, 4, 253-265. 14. Bershadsky, A.D.; Vasiliev, J.M. Cytoskeleton; Plenum Press: New York, NY, USA, 1988. 15. Stanton, R.A.; Gernert, K.M.; Nettles, J.H.; Aneja, R. Drugs that target dynamic microtubules: A new molecular perspective. Med. Res. Rev. 2011, 31, 443-481. 16. Li, W.; Zhao, Y.; Gantz, D.L.; Chou, I.-N. Nickel (Ni2+) enhancement of microtubule assembly is dependent on GTP function. Toxicol. Appl. Pharmacol. 2003, 193, 202-208. 17. Li, W.; Zhao, Y.; Chou, I.-N. Mg2+ antagonism on Ni2+-induced changes in microtubule assembly and cellular thiol homeostasis. Toxicol. Appl. Pharmacol. 1996, 136, 101-111.